Advertisement

 

 

Hepatic and Intra-abdominal Tuberculosis: 2016 Update.

Hepatic and Intra-abdominal Tuberculosis: 2016 Update.
Author Information (click to view)

Evans RP, Mourad MM, Dvorkin L, Bramhall SR,


Evans RP, Mourad MM, Dvorkin L, Bramhall SR, (click to view)

Evans RP, Mourad MM, Dvorkin L, Bramhall SR,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Current infectious disease reports 18(12) 45

Abstract

Mycobacterium tuberculosis (TB) infection affects nearly 10 million people a year and causes 1.5 million deaths. TB is common in the immunosuppressed population with 12 % of all new diagnoses occurring in human immune deficiency virus (HIV)-positive patients. Extra-pulmonary TB occurs in 12 % of patients with active TB infection of which 3.5 % is hepatobiliary and 6-38 % is intra-abdominal. Hepatobiliary and intra-abdominal TB can present with a myriad of non-specific symptoms, and therefore, diagnosis requires a high level of suspicion. Accurate and rapid diagnosis requires a multidisciplinary team (MDT) approach using radiology, interventional radiology, surgery and pathology services. Treatment of TB is predominantly medical, yet surgery plays an important role in managing the complications of hepatobiliary and intra-abdominal TB.

Submit a Comment

Your email address will not be published. Required fields are marked *

1 × 2 =

[ HIDE/SHOW ]